Joaquin Martinez-Mosquera - Publications

Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study).

Journal: Cancers

Published: September 21, 2025

Real-world clinical experience with osimertinib in advanced EGFR-mutated non-small cell lung cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 06, 2025

Assessment of efficacy, safety, and prognostic/predictive factors of nintedanib/docetaxel in advanced/recurrent non-small cell lung cancer post-immunotherapy and chemotherapy: A Galician Lung Cancer Group study.

Journal: Cancer treatment and research communications

Published: March 13, 2025

Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial.

Journal: The Lancet. Oncology

Published: January 27, 2025

Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study.

Journal: Translational lung cancer research

Published: July 09, 2021

The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer.

Journal: Journal of clinical medicine

Published: October 13, 2020

Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 21, 2020

Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group.

Journal: Journal of geriatric oncology

Published: July 24, 2020

Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy.

Journal: Translational lung cancer research

Published: February 04, 2020

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.

Journal: The Lancet. Oncology

Published: December 03, 2019

Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience.

Journal: Translational lung cancer research

Published: July 28, 2018